Drug Patent Expirations in June 2011

Drug Patent Expirations in June 2011

*Drugs may be covered by multiple patents



Tradename Applicant Generic Name Patent Number Patent Expiration
FEMARA Novartis Pharms letrozole 4,978,672 Jun 3, 2011
TAZORAC Allergan tazarotene 5,089,509 Jun 13, 2011
AVAGE Allergan tazarotene 5,089,509 Jun 13, 2011
NUEDEXTA Avanir Pharms dextromethorphan hydrobromide; quinidine sulfate 5,166,207 Jun 17, 2011
PATADAY Alcon olopatadine hydrochloride 5,116,863*PED Jun 18, 2011
PATANOL Alcon olopatadine hydrochloride 5,116,863*PED Jun 18, 2011
PATANASE Alcon olopatadine hydrochloride 5,116,863*PED Jun 18, 2011
LEVAQUIN Ortho Mcneil Janssen levofloxacin 5,053,407*PED Jun 20, 2011
LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER Ortho Mcneil Pharm levofloxacin 5,053,407*PED Jun 20, 2011
LEVAQUIN Ortho Mcneil Pharm levofloxacin 5,053,407*PED Jun 20, 2011
DILTIAZEM HYDROCHLORIDE Biovail diltiazem hydrochloride 5,288,505 Jun 26, 2011
BAYCOL Bayer Pharms cerivastatin sodium 5,006,530 Jun 26, 2011
CARDIZEM LA Biovail Labs Intl diltiazem hydrochloride 5,288,505 Jun 26, 2011
COVERA-HS Gd Searle Llc verapamil hydrochloride 5,160,744 Jun 27, 2011
COVERA-HS Gd Searle Llc verapamil hydrochloride 5,252,338 Jun 27, 2011
ELIGARD Tolmar Therap leuprolide acetate 5,324,519 Jun 28, 2011
LIPITOR Pfizer atorvastatin calcium RE40667*PED Jun 28, 2011
LIPITOR Pfizer atorvastatin calcium 5,273,995*PED Jun 28, 2011
CADUET Pfizer amlodipine besylate; atorvastatin calcium 5,273,995*PED Jun 28, 2011
CADUET Pfizer amlodipine besylate; atorvastatin calcium RE40667*PED Jun 28, 2011

This information is also available in an email newsletter: Subscribe to the DrugPatentWatch Patent Expiration Bulletin. Courtesy of DrugPatentWatch.com


Leave a Reply